Donald T. Gardner III Sells 3,000 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $40.01, for a total value of $120,030.00. Following the completion of the transaction, the chief financial officer now directly owns 18,358 shares of the company’s stock, valued at approximately $734,503.58. This trade represents a 14.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Kewaunee Scientific Price Performance

NASDAQ:KEQU opened at $40.15 on Friday. The company has a market capitalization of $114.63 million, a price-to-earnings ratio of 6.36 and a beta of 0.71. The company has a 50-day moving average of $55.79 and a 200-day moving average of $47.47. Kewaunee Scientific Co. has a 52 week low of $30.82 and a 52 week high of $71.33. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The company had revenue of $67.17 million for the quarter.

Institutional Trading of Kewaunee Scientific

A number of large investors have recently bought and sold shares of the stock. Minerva Advisors LLC grew its holdings in shares of Kewaunee Scientific by 4.1% in the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company’s stock worth $6,668,000 after purchasing an additional 4,311 shares during the last quarter. Invesco Ltd. bought a new stake in shares of Kewaunee Scientific during the fourth quarter worth $6,545,000. De Lisle Partners LLP increased its stake in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after buying an additional 11,511 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Kewaunee Scientific by 18.0% in the fourth quarter. American Century Companies Inc. now owns 34,293 shares of the technology company’s stock valued at $2,122,000 after buying an additional 5,221 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its position in Kewaunee Scientific by 3.3% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 28,008 shares of the technology company’s stock worth $1,733,000 after buying an additional 891 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research note on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.